Investigation of infertility with the emphasis on laboratory testing and with reference to radiological imaging

Journal of Clinical Pathology

Volumn 56, Issue 4, 2003, Pages 261-267

  Williams, C ^a   Giannopoulos, T ^a   Sherriff, E A ^a  

^a ST HELIER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; PRASTERONE; BIOLOGICAL MARKER; HORMONE; PROGESTERONE;

CLINICAL PRACTICE; EMBRYOLOGY; ENDOMETRIUM BIOPSY; ENVIRONMENTAL FACTOR; ESTRADIOL BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYSTEROSALPINGOGRAPHY; IMAGING SYSTEM; INFERTILITY; INFERTILITY THERAPY; LABORATORY TEST; LAPAROSCOPY; LUTEINIZING HORMONE BLOOD LEVEL; MEDICAL RECORD; MICROBIOLOGICAL EXAMINATION; NONHUMAN; POSTCOITAL TEST; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; RADIOLOGY; REVIEW; SALIVA ANALYSIS; SEMEN ANALYSIS; SPERMATOZOON PENETRATION; STEROID ANALYSIS; SUBFERTILITY; TESTOSTERONE BLOOD LEVEL; THYROID GLAND EXAMINATION; ULTRASOUND; BLOOD; CLINICAL PROTOCOL; DIAGNOSIS, MEASUREMENT AND ANALYSIS; FEMALE; FEMALE INFERTILITY; MALE; MALE INFERTILITY; METHODOLOGY; PHYSIOLOGY; QUALITY CONTROL; SPERMATOZOON;

BENCHMARKING; BIOLOGICAL MARKERS; CLINICAL LABORATORY TECHNIQUES; CLINICAL PROTOCOLS; FEMALE; HORMONES; HUMANS; HYSTEROSALPINGOGRAPHY; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; PROGESTERONE; SPERMATOZOA;

EID: 0037391627     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.4.261     Document Type: Review

References (74)

1. Templeton A, Fraser C, Thompson B. Infertility - epidemiology and referral practice. Hum Reprod 1991;6:1391-4.
2. Van Voorhis BJ, Stovall DW, Allen BD, et al. Cost-effective treatment of the infertile couple. Fertil Steril 1998;70:995-100S.
3. Effective Health Care. Implementing clinical practice guidelines: can guidelines be used to improve clinical practice? Effective Health Care Bulletin 1994;8. London: Royal Society of Medicine Press.
4. Taylor PJ, Collins JA. Unexplained infertility. Oxford: Oxford University Press, 1992.
5. Seth J, Sturgeon CM, Ellis AR, et al. United Kingdom External Quality Assessment Scheme (NEQAS) for Peptide Hormones and Related Substances. Annual review 2000. Department of Clinical Biochemistry, Royal Infirmary, Edinburgh EH3 9YW, UK.
6. Seth J, Sturgeon CM, Ellis AR, et al. United Kingdom External Quality Assessment Scheme (NEQAS) for Peptide Hormones and Related Substances. Annual review 1997. Department of Clinical Biochemistry, Royal Infirmary, Edinburgh EH3 9YW, UK.
7. Thomas A. Wales External Quality Assessment Scheme (WEQAS), Endocrine Scheme. Annual report 1999. Quality Laboratory, Directorate of Pathology, University Hospital of Wales, Heath Park, Cardiff CF4 4XW, UK.
8. Bjoro T, Morkrid L, Wergeland R, et al. Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL). Scand J Clin Lab Invest 1995;55:139-47.
9. Soong YK, Ferguson KM, McGorrick G, et al. Size heterogeneity of immunoreactive prolactin in hyperprolactinaemia serum. Clin Endocrinol 1982;16:256-65.
10. Fahie-Wilson MN, Soule SG. Macroprolactinaemia: contribution of hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem 1997;34:252-8.
11. Klockenbush W, Distler W, von Ditfurth M, et al. The value of functional tests in diagnosis of prolactinoma. Geburtshilfe Frauenheilkd 1990;50:383-7.
12. Leslie H, Courtney CH, Bell PM, et al. Laboratory and clinical experience in 55 patients with macroprolactinaemia identified by a simple polyethylene glycol precipitation method. J Endocrinol Metab 2001;86:2743-6.
13. Hauache OM, Rochat AJ, Maia ACM, et al. Screening for macroprolactinaemia and pituitary imaging studies. Clin Endocrinol 2002;57:327-31.
14. Ferriani RA, Silva de Sa MF. Effect of venipuncture stress on plasma prolactin levels. Int J Gynaecol Obstet 1985;23:459-62.
15. Ishay A, Luboghitzky R. Diagnosis of hyperprolactinemia: determination of prolactin level at rest. Harefuah 1998;135:348-50, 408, 407.
16. Muneyyirci-Delale O, Goldstein D, Reyes FI. Diagnosis of stress-related hyperprolactinemia. Evaluation of the hyperprolactinemia rest test. N Y State J Med 1989;89:205-8.
17. Pereira MC, Sobrinho LG, Afonso AM, et al. Is idiopathic hyperprolactinemia a transient stage towards prolactinoma? Obstet Gynecol 1987;70:305-8.
18. Kurioka H, Takahashi K, Irikoma M, et al. Diagnostic difficulty in polycystic ovary syndrome due to an LH-beta-subunit variant. Eur J Endocrinol 1999;140:235-8.
19. World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. Cambridge: Cambridge University Press, 1999.
20. Kremer J, Jager S. The significance of antisperm antibodies for sperm-cervical mucus interaction. Hum Reprod 1992;7:781-4.
21. Hughes IA, Read GF. Simultaneous plasma and salivary steroid measurements as an index of control in congenital adrenal hyperplasia (CAH). A longitudinal study. Horm Res 1982;16:142-50.
22. Ohtaki T, Moriyoshi M, Nakada K, et al. Radioimmunoassay of saliva estrone sulfate in pregnant sows. J Vet Med Sci 1997;59:759-63.
23. Mounib N, Sultan C, Bringer J, et al. Correlations between free plasma estradiol and estrogens determined by bioluminescence in saliva, plasma and urine during spontaneous and FSH stimulated cycles in women. J Steroid Biochem 1998;31:861-5.
24. Gaskell SJ, Finlay EM, Pike AW. Analyses of steroids in saliva using highly selective mass spectrometric techniques. Biomed Mass Spectrom 1980;7:500-4.
25. Bolaji II, Tallon DF, O'Dwyer E, et al. Assessment of bioavailability of oral micronized progesterone using a salivary progesterone enzymeimmunoassay. Gynecol Endocrinol 1993;7:101-10.
26. Swinkels LM, van Hoof HJ, Ross HA, et al. Low ratio of androstenedione to testosterone in plasma and saliva of hirsute women. Clin Chem 1992;38:1819-23.
27. Lac G, Lac N, Robert A. Steroid assays in saliva: a method to detect plasmatic contaminations. Arch Int Physiol Biochim Biophys 1993;101:257-62.
28. Filaire E, Lac G. Dehydroepiandrosterone (DHEA) rather than testosterone shows saliva androgen responses to exercise in elite female handball players. Int J Sports Med 2000;21:17-20.
29. Vining RF, McGinley RA. Hormones in saliva. Crit Rev Clin Lab Sci 1986;23:95-146.
30. Vining RF, McGinley RA. The measurement of hormones in saliva: possibilities and pitfalls. J Steroid Biochem 1987;27:81-94.
31. Walker RF, Read GF, Wilson DW, et al. Chronobioiogy in laboratory medicine; principles and clinical applications illustrated from measurements of neutral steroids in saliva. Prog Clin Biol Res 1990;341A:105-17.
32. Smith RG, Besch PK, Dill B, et al. Saliva as a matrix for measuring free androgens: comparison with serum androgens in polycystic ovarian disease. Fertil Steril 1979;31:513-17.
33. Seinkels LM, van Hoof HJ, Ross HA, et al. Concentrations of salivary testosterone and plasma total, non-sex-hormone-binding globulin-bound, and free testosterone in normal and hirsute women during administration of dexamethasone/synthetic corticotropin. Clin Chem 1991;37:139-40.
34. Swinkels LM, van Hoof HJ, Ross HA, et al. Low ratio of androstenedione to testosterone in plasma and saliva of hirsute women. Clin Chem 1992;38:1819-23.
35. Tschop M, Behre HM, Nieschlag E, et al. A time-resolved fluorescence immunoassay for the measurement of testosterone in saliva: monitoring of testosterone replacement therapy with testosterone buciclate. Clin Chem Lab Med 1998;36:223-30.
36. Riad-Fahmy D, Read GF, Walker RF. Salivary steroid assays for assessing variation in endocrine activity. J Steroid Biochem 1983;19:265-72.
37. Fulton A, Chan S, Coleman G. Effect of salivary proteins on binding curves of three radioimmunoassay kits: Amerlex-M progesterone, Amerlex cortisol, and Biodata testosterone. Clin Chem 1989;35:641-4.
38. Dabbs JM, Campbell BC, Gladue BA, et al. Reliability of salivary testosterone measurements: a multicenter evaluation. Clin Chem 1995;41:1581-4.
39. Royal College of Obstetricians and Gynaecologists. Infertility-guidelines for practice. London: RCOG Press, 1992.
40. Rowe PJ, Comhaire FH, Hargreave TB, et al. WHO manual for the standardised investigation and diagnosis of the infertile couple. Cambridge: Cambridge University Press, 1993.
41. Speroff L, Glass RH, Kase N. Regulation of the menstrual cycle. In: Clinical gynecologic endocrinology and fertility, 5th ed. Baltimore: Williams & Wilkins 1994:809.
42. Speroff L, Glass H, Kase G. Clinical gynecologic endocrinology and infertility, 5th ed. Baltimore: Williams & Wilkins, 1994.
43. Illions EH, Valley MT, Kaunitz AM. Infertility: a clinical guide for the internist. Womens Health Issues, Port II 1998;82.
44. Arojoki M, Jokimao V, Juuti A, et al. Hypothyroidism among infertile women in Finland. Gynecol Endocrinol 2000;14:127-31.
45. Van Santbrink EJ, Hop WC, Fauser BC. Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril 1997;67:452-8.
46. Dramusic V, Gob VH, Rajan U, et al. Clinical, endocrinologic, and ultrasonographic features of polycystic ovary syndrome in Singaporean adolescents. J Pediatr Adolesc Gynecol 1997;10:125-32.
47. Dewailly D. Definition and significance of polycystic ovaries. Baillieres Clin Obstet Gynaecol 1997;11:349-68.
48. Fauser BC, Pache TD, Hop WC, et al. The significance of a single serum LH measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates. Clin Endocrinol 1992;37:445-52.
49. Fox R, Corrigan E, Thomas PA, et al. The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: predictive power of endocrine tests. Clin Endocrinol 1991;34:127-31.
50. Koskinen P, Penttila TA, Anttila L, et al. Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome. Fertil Steril 1996;65:517-22.
51. Robinson S, Rodin DA, Deacon A, et al. Which hormone tests for the diagnosis of polycystic ovary syndrome? Br J Obstet Gynaecol 1992;99:232-8.
52. Montalto J, Funder JW, Yong AB, et al. Serum 5-androstene-3 beta, 17 betadiol sulphate and 5 alpha-androstane-3 alpha, 17 beta-diol sulphate in hirsute females with polycystic ovarian disease. J Steroid Biochem 1990;36:67-74.
53. Turhan NO, Toppare MF, Seckin NC, et al. The predictive power of endocrine tests for the diognosis of polycystic ovaries in women with oligoamenorrhea. Gynecol Obstet Invest 1999;48:183-6.
54. Oppermann K, Cho MM, Spritzer PM. Serum levels in hirsute anovulatory women. Braz J Med Biol Res 1993;26:799-803.
55. Collet C, Lecomte P, Guilloteau D, et al. Luteinizing hormone measurement in polycystic ovary syndrome: a practical approach. Eur J Endocrinol 1999;141:225-30.
56. Hagag P, Ben-Shlomo A, Herzianu I, et al. Diagnosis of polycystic ovary disease in obese women with a 24 hour hormone profile after buserelin stimulation. J Reprod Med 2000;45:171-8.
57. Gandar R, Spizzo M, Collin D. Diagnosis and treatment of polycystic ovary syndrome. J Gynecol Obstet Biol Reprod (Paris) 1999;28:510-18.
58. Irvine OS, Aitken RJ. Seminal fluid analysis and sperm function testing. Endocr Metab Clin North Am 1994;23:725-48.
59. Chamberlain G, Brown JC. Gynaecological laparoscopy-the report of the working party of the confidential enquiry into gynaecological laparascopy. London: RCOG Press, 1978.
60. Cerda-Flores RM, Barton SA, Marty-Gonzalez LF, et al. Estimation of nonpaternity in the Mexican population of Nuevo Leon: a validation study with blood group markers. Am J Phys Anthopol 1999;109:281-93.
61. Macintyre S, Sooman A. Non-paternity and prenatal genetic screening. Lancet 1991;338:869-71.
62. Brock DGH, Shrimpton AE. Non-paternity and prenatal genetic screening. Lancet 1991;338:1151.
63. Sykes B, Irven C. Surnames and the Y chromosome. Am J Hum Genet 2000;66:1417-19.
64. Atkinson AD. United Kingdom External Control Assessment Scheme. Annual Report 1999-2000. Sub-Fetiltity Laboratory, St Mary's Hospital, Hathersage Road, Manchester, M13 OJH.
65. United Kingdom External Control Assessment Scheme. Sub-Fetiltity Laboratory, St Mary's Hospital, Hathersage Road, Manchester, M13 OJH.
66. Chandley AC. The chromosomal basis of human infertility. BMJ 1979;35:181-6.
67. The management of infertility in secondary care. Evidence based guidelines no 3. Royal London: College of Obstetricians and Gynaecologists, February 1998.
68. Barratt CLR, McLeod IO, Ounphy B, et al. Prognostic value of two putative sperm function tests: hypo-osmotic swelling and bovine sperm mucus penetration test (Penetrak). Hum Reprod 1992;7:1240-4.
69. Aitken RJ, Irvine DS, Wu FC. Prospective analysis of sperm-oocyte fusion and reactive oxygen species generation as a criteria for the diagnosis of fertility. Am J Obstet Gynecol 1991;164:542-51.
70. Matson PL. Detection and clinical significance of sperm antibodies. In: Grudzinskas JG, Yovich JL, Chard T, eds. Cambridge reviews in human reproduction. Cambridge: Cambridge University Press, 1994.
71. The initial management and investigations of the infertile couple. Evidence based guidelines no 2. London: Royal College of Obstetricians and Gynaecologists, February 1998.
72. Haas GGJ. Antisperm antibodies in infertile men. J Am Med Assoc 1996;275:885-6.
73. Clarke GN, Elliott PJ, Smaila C. Detection of sperm antibodies in semen using the Immunobead test: a survey of 813 consecutive patients. Am J Reprod Immunol Microbiol 1985;7:118-23.
74. The management of infertility in tertiary care. Evidence based guidelines no 6. Royal London: College of Obstetricians and Gynaecologists, January 2000.